- Home
- GOSS vs LNKB Comparison
GOSS vs LNKB Comparison
Compare GOSS & LNKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- LNKB
- Stock Information
- Founded
- GOSS 2015
- LNKB 2018
- Country
- GOSS United States
- LNKB United States
- Employees
- GOSS N/A
- LNKB N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- LNKB
- Sector
- GOSS Health Care
- LNKB
- Exchange
- GOSS Nasdaq
- LNKB Nasdaq
- Market Cap
- GOSS 262.5M
- LNKB 256.4M
- IPO Year
- GOSS 2019
- LNKB N/A
- Fundamental
- Price
- GOSS $1.40
- LNKB $6.66
- Analyst Decision
- GOSS Strong Buy
- LNKB Strong Buy
- Analyst Count
- GOSS 4
- LNKB 1
- Target Price
- GOSS $7.75
- LNKB $9.00
- AVG Volume (30 Days)
- GOSS 1.3M
- LNKB 33.9K
- Earning Date
- GOSS 08-11-2025
- LNKB 07-28-2025
- Dividend Yield
- GOSS N/A
- LNKB 4.42%
- EPS Growth
- GOSS N/A
- LNKB N/A
- EPS
- GOSS N/A
- LNKB 0.97
- Revenue
- GOSS $124,590,000.00
- LNKB $120,786,000.00
- Revenue This Year
- GOSS N/A
- LNKB $21.23
- Revenue Next Year
- GOSS $91.14
- LNKB N/A
- P/E Ratio
- GOSS N/A
- LNKB $7.05
- Revenue Growth
- GOSS N/A
- LNKB 135.60
- 52 Week Low
- GOSS $0.55
- LNKB $5.86
- 52 Week High
- GOSS $1.55
- LNKB $7.98
- Technical
- Relative Strength Index (RSI)
- GOSS 57.95
- LNKB 40.55
- Support Level
- GOSS $1.22
- LNKB $6.66
- Resistance Level
- GOSS $1.36
- LNKB $7.23
- Average True Range (ATR)
- GOSS 0.08
- LNKB 0.18
- MACD
- GOSS -0.00
- LNKB -0.03
- Stochastic Oscillator
- GOSS 66.07
- LNKB 8.06
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About LNKB LINKBANCORP Inc.
Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans. Company portfolio segments includes: Agriculture and farmland, Construction, Commercial & industrial, Commercial real estate, Residential real estate, Municipal, customers and Other loans.